Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens

Nafithromycin (WCK 4873) is a novel lactone ketolide antibiotic developed to address the critical issue of multidrug-resistant bacteria, especially those causing community-acquired pneumonia (CAP). Given the increasing prevalence of antibiotic resistance, there is a pressing need for new antibiotic...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Akshata Gore, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	PAGEPress Publications 2025-08-01
Σειρά:	Monaldi Archives for Chest Disease
Θέματα:	Nafithromycin community-acquired pneumonia multidrug-resistant bacteria lactone ketolide antibiotic pharmacokinetics
Διαθέσιμο Online:	https://www.monaldi-archives.org/macd/article/view/3340
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!